Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivoYuchen Zhang(Sun Yat-sen University Cancer Center), Ning Liao(Guangdong Academy of Medical Sciences)Cell Communication and SignalingSeptember 14, 202210.1186/s12964-022-00955-8Cited by 33SaveCiteExport RISWatch citationsRelated PapersGenomic alteration profile and <scp>PD‐L1</scp> expression among different breast cancer subtypes in Chinese population and their correlations|Cancer Medicine|2022|4